Your browser doesn't support javascript.
loading
Anifrolumab for Adolescent Discoid Lupus Erythematosus.
Shaw, Katharina S; Rajeh, Ahmad; Le, Todd; Kahn, Philip J; Oza, Vikash S; Arkin, Lisa M; Vleugels, Ruth Ann.
Afiliação
  • Shaw KS; Department of Dermatology, Perelman School of Medicine, University of Pennsylvania, Philadelphia.
  • Rajeh A; Section of Dermatology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.
  • Le T; Department of Dermatology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
  • Kahn PJ; Department of Dermatology, University of Wisconsin School of Medicine and Public Health, Madison.
  • Oza VS; Department of Pediatrics, University of Wisconsin School of Medicine and Public Health, Madison.
  • Arkin LM; Division of Pediatric Rheumatology, Department of Pediatrics, Hassenfeld Children's Hospital at NYU Langone Health, New York University Grossman School of Medicine, New York.
  • Vleugels RA; Division of Pediatric Rheumatology, Department of Pediatrics, Hassenfeld Children's Hospital at NYU Langone Health, New York University Grossman School of Medicine, New York.
JAMA Netw Open ; 6(10): e2338200, 2023 10 02.
Article em En | MEDLINE | ID: mdl-37851448
This case series describes the outcomes among adolescent patients with systemic lupus erythematosus and refractory discoid lupus erythematosus treated with anifrolumab.
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Lúpus Eritematoso Discoide / Anticorpos Monoclonais Humanizados Limite: Adolescent / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Lúpus Eritematoso Discoide / Anticorpos Monoclonais Humanizados Limite: Adolescent / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article